Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

BMS to invest US$ 40 bn to boost US manufacturing, R&D; 19 states sue Trump admin for gutting health agencies

US President Donald Trump’s tariff threats appear to be working, as Bristol Myers Squibb became the latest drugmaker to a...

Impressions : 1217

AbbVie, Amgen, Thermo Fisher to invest in US manufacturing to avoid tariffs; Merck KGaA acquires SpringWorks for US$ 3.9 bn

Ever since US President Donald Trump has talked about a “major tariff” on drug imports coming “very shortly&r...

Impressions : 657

Roche announces US$ 50 bn investment in US to avoid tariffs; Regeneron signs US$ 3 bn onshoring deal with Fujifilm

After Eli Lilly, Johnson & Johnson and Novartis, Roche has announced plans to manufacture in the US to avoid tariffs. The Swiss...

Impressions : 890

Novartis to invest US$ 23 bn in US to avoid import tariffs; Pfizer halts development of GLP-1 weight-loss pill

After Eli Lilly and Johnson & Johnson, Novartis has become the latest big pharma to announce mega investments in the US. The ...

Impressions : 872

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

BMS to invest US$ 40 bn to boost US manufacturing, R&D; 19 states sue Trump admin for gutting health agencies

AbbVie, Amgen, Thermo Fisher to invest in US manufacturing to avoid tariffs; Merck KGaA acquires SpringWorks for US$ 3.9 bn

Roche announces US$ 50 bn investment in US to avoid tariffs; Regeneron signs US$ 3 bn onshoring deal with Fujifilm

Novartis to invest US$ 23 bn in US to avoid import tariffs; Pfizer halts development of GLP-1 weight-loss pill

BeiGene's Biologics Tevimbra Receives Suppl Approval in US

Graviti Pharma's Generics Tamsulosin HCl Receives Approval in US

Aspiro's Generics Zinc Sulfate Receives Approval in US

Sterinova's Generics Midazolam NaCl Receives Approval in US

Apotex's Generics Ticagrelor Receives Tentative Approval in US

Apotex's Generics Ticagrelor Receives Approval in US

Amgen's Biologic Blincyto Receives Approval in US

Kashiv Bio's Biologic Releuko Receives Approval in US

Janssen's Biologic NIpocalimab Receives Approval in US

Celltrion's Biologic Steqeyma Receives Suppl Approval in US

Cosco International Receives FDA Warning Letter

Dyno Manufacturing Receives FDA Warning Letter

Beo Pharmaceuticals Receives FDA Warning Letter

Enforcement Report - Week of April 23, 2025

Amneal Issues a Nationwide Recall of Ropivacaine HCl

Enforcement Report - Week of April 16, 2025

PMS4PMS Receives FDA Warning Letter

Enforcement Report - Week of April 2, 2025

FDA Issues Form 483 to Revive Rx LLC

FDA Issues Form 483 to Eagle Pharma Outsourcing LLC

FDA grants Verastem 1st approval for rare ovarian cancer treatment

Suven Pharmaceuticals is now Cohance Lifesciences

Novavax Sales Jump 600% YoY as COVID-19 Vaccine, Limbo at FDA

GSK posts phase 3 itch data as it closes in on FDA approval

Takeda eyes upcoming launches as Vyvanse generics hit lingers

FDA misses target date for GSK's Nucala in COPD

Gilead tees up $11B in new US manufacturing, R&D investments

FDA centers to deploy AI internally, following experimental run

Trump administration health research cuts total $1.8 billion

Zelluna ASA Reports Q1 2025 Financial Results and Business Update

Takeda eyes upcoming launches as Vyvanse generics hit lingers

Senores Pharmaceuticals acquires ANDA for Topiramate HCl tablets

Class Action Over Generic Clobetasol And Clomipramine

Formosa Pharmaceuticals Licenses Clobetasol Propionate to Apotex

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia

Alembic gets USFDA final approval for Ticagrelor Tablets

Gland Pharma gets USFDA approval for Latanoprostene Buno

MotoAmerica First to Use Abbott's Rapid Blood Test for Concussion

Strides Pharma gets USFDA approval for Celecoxib Capsules

Zydus Lifesciences approved by USFDA for generic cholesterol Drug

Novavax Sales Jump 600% YoY as COVID-19 Vaccine, Limbo at FDA

FDA misses target date for GSK's Nucala in COPD

FDA advisers to discuss COVID-19 vaccine recommendations on May 22

Sarepta sees delays in treatment after Elevidys death report

CRISPR Tx sees 80% fall in LDL, triglycerides after in vivo edit

Marea rises toward phase 2b after posting cholesterol data

Recludix Presents Data on First-in-Class BTK SH2 Domain Inhibitor

Eupraxia Pharmaceuticals to Host Virtual KOL Event on May 9, 2025

IN8bio Reports Q1 2025 Financial Results and Business Highlights

Bionano to Report Q1 2025 Results, Host Conference Call May 14

SMS Pharmaceuticals Vizag plant gets WHO Geneva prequalification

API China 2025: Explore Chenghuis GMP-Certified Portfolio

Efficient project management in pharma: 8 steps to optimize

Myomo Launches the MyoPro® 2x

May 21, 2025 General Meeting - Preparatory documents available

Morepen Laboratories expands its domestic portfolio

CARBOGEN AMCIS Shanghai Site Gets Drug Manufacturing License

Divi's Lab inks supply pact with global pharmaceutical entity

Sustainability in Pharma Manufacturing: Path to Greener Future

Pharma companies may feel heat of US tariffs on China

Innoxel Lifesciences completes USFDA inspection

AGES inspects Shilpa Biologicals' Dharwad site in Europe

Bausch + Lomb identifies cause of intraocular lens recall

Masimo reports cyber attack slowing manufacturing, sales

Neuland Laboratories completes USFDA inspection at Unit 2

USFDA inspection at Concord Biotechs API facility at Dholka

QPS India Completes Week-Long US FDA Inspection

USFDA inspects Marksans subsidiary Time-Cap Laboratories

America's 2nd Obesity Crisis Is Disinformation

Ranitidine ban deferred despite cancer concerns

Acumen Pharmaceuticals at Bank of America Healthcare Conference

scPharmaceuticals to Announce Q1 2025 Financial Results on May 14

RxSight Reports First Quarter 2025 Financial Results